New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
Recruiting · NCT06622434 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-11 | NCT06622434 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ALTEVAX SAS | 1 |
| Assistance Publique - Hôpitaux de Paris | 985 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Neurology, Hopital de la Salpêtrière | Paris | France | 1 |
| Department of Neurology, Hopital Saint louis (APHP) | Paris | France | 1 |
| Neuro-oncology Department, La Timone Hospital | Marseille | France | 1 |